| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Biogen | 0 | 0 |
| Item No. | 1 |
|---|---|
| Lender's Name | Mark Berens |
| Lender's Title | Chairman & CEO |
| Original Amount of Loan | 1013891 |
| Balance Due | 1288437 |
| Date of Note | 2022-01 |
| Maturity Date | 2023-04 |
| Repayment Terms | This |
| Interest Rate | |
| Security Provided by Borrower | NA |
| Purpose of Loan | NA |
| Description of Lender Consideration | NA |
| Consideration FMV | 1288437 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| Other Asset | 1,334 | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Insruance | 47,127 | 0 | 0 | 47,127 |
| Computer & Software | 379 | 0 | 0 | 379 |
| Office Services - Payroll Services | 1,305 | 0 | 0 | 1,305 |
| Business Fees | 130 | 0 | 0 | 130 |
| 401k Administration | 3,135 | 0 | 0 | 3,135 |